InBody Co.,Ltd (KOSDAQ:041830)

Market Cap	366.99B
Revenue (ttm)	226.62B
Net Income (ttm)	32.83B
Shares Out	12.19M
EPS (ttm)	2,626.56
PE Ratio	11.46
Forward PE	10.58
Dividend	400.00 (1.32%)
Ex-Dividend Date	Mar 28, 2025

Volume	20,594
Average Volume	30,149
Open	30,450
Previous Close	30,400
Day's Range	29,950 - 30,450
52-Week Range	21,400 - 35,000
Beta	0.45
RSI	42.51
Earnings Date	Feb 20, 2026

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. It offers body composition analyzers, automatic blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 1996
• Employees: 342
• Stock Exchange: KOSDAQ
• Ticker Symbol: 041830

Financial Performance

In 2024, InBody Co.,Ltd's revenue was 204.46 billion, an increase of 20.03% compared to the previous year's 170.35 billion. Earnings were 33.14 billion, a decrease of -9.75%.